SandyAssist, a Revolutionary AI Tool Set to Transform Productivity for Professionals and Students, has Launched
The Power of GPT-3.5 AI Combined with AWS Brings Advanced Content Creation to the Fingertips…
Year: 2023
Food Fortification a Major Focus at the World Health Assembly
Geneva, Switzerland, May 22, 2023 – (ACN Newswire) – The crucial topics of micronutrient deficiencies…
Kazakhstan-Singapore Business Forum: ONERHT leads investment in Kazakhstan gold mining company
Astana, Kazakhstan, May 22, 2023 – (ACN Newswire) – RHT AlDigi Financial Holdings Pte. Ltd….
Mastercard and HealthLock partner to help protect consumers from healthcare fraud and billing errors
Online platform helps organize every medical insurance claim through one user-friendly dashboard PURCHASE, N.Y.–(BUSINESS WIRE)–Mastercard…
Esperanto Technologies Expands Global Partner Network
Company’s Partners Add System Integration and Solutions Expertise As Well As Enhanced Access to US,…
Former NGA Director Robert Cardillo Appointed to Synthetaic’s Board of Directors
Leveraging decades of experience, Cardillo will help guide Synthetaic to shape the future of geospatial…
Addison Group EVP, Peg Buchenroth, Awarded for Excellence in Diversity & Inclusion by Staffing Industry Analysts, SIA
CHICAGO–(BUSINESS WIRE)–Addison Group Executive Vice President, Human Resources, Peg Buchenroth is recognized on SIA’s Diversity,…
Don’t Let Your IoT Devices Threaten Network Security
By Roger Sands, CEO and Co-Founder of Wyebot Internet of Things (IoT) technology is rapidly…
How Cybersecurity Can Keep Pace with Digital Science and AI Capabilities
By Rachel Jenkins Digital science aims to improve old processes with new and innovative technologies,…
PolyPid Announces FDA Agreement on the Design of SHIELD II Phase 3 Trial Evaluating D-PLEX₁₀₀ for Prevention of Abdominal Colorectal Surgical Site Infections
Recruitment to Resume Imminently Top-line Results Expected in Mid-2024 PETACH TIKVA, Israel, May 22, 2023 (GLOBE…
PolyPid Announces FDA Agreement on the Design of SHIELD II Phase 3 Trial Evaluating D-PLEX₁₀₀ for Prevention of Abdominal Colorectal Surgical Site Infections
Recruitment to Resume Imminently Top-line Results Expected in Mid-2024 PETACH TIKVA, Israel, May 22, 2023 (GLOBE…
Medigene AG Expands Patent Portfolio for its End-to-End Platform
Planegg/Martinsried, May 22, 2023. Medigene AG (Medigene, FSE: MDG1, Prime Standard), an immuno-oncology platform company…
Medigene AG Expands Patent Portfolio for its End-to-End Platform
Planegg/Martinsried, May 22, 2023. Medigene AG (Medigene, FSE: MDG1, Prime Standard), an immuno-oncology platform company…
Keros Therapeutics Presents Preclinical and Clinical Data from its KER-012 Program at the American Thoracic Society International Conference
LEXINGTON, Mass., May 22, 2023 (GLOBE NEWSWIRE) — Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS), a…
Keros Therapeutics Presents Preclinical and Clinical Data from its KER-012 Program at the American Thoracic Society International Conference
LEXINGTON, Mass., May 22, 2023 (GLOBE NEWSWIRE) — Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS), a…
Tilray Brands Chairman and CEO Irwin D. Simon to Participate in the Bernstein 39th Annual Strategic Decisions Conference
NEW YORK, May 22, 2023 (GLOBE NEWSWIRE) — Tilray Brands, Inc. (“Tilray”) (Nasdaq: TLRY; TSX:…
Tilray Brands Chairman and CEO Irwin D. Simon to Participate in the Bernstein 39th Annual Strategic Decisions Conference
NEW YORK, May 22, 2023 (GLOBE NEWSWIRE) — Tilray Brands, Inc. (“Tilray”) (Nasdaq: TLRY; TSX:…
Quanta Therapeutics Raises Over $50 Million in Series D Financing to Advance its Pipeline of KRAS Inhibitors
– Funds will support advancement of two KRAS inhibitor programs into the clinic in 2024…
Quanta Therapeutics Raises Over $50 Million in Series D Financing to Advance its Pipeline of KRAS Inhibitors
– Funds will support advancement of two KRAS inhibitor programs into the clinic in 2024…
Lumos Pharma to Participate in World Orphan Drug Congress USA
AUSTIN, Texas, May 22, 2023 (GLOBE NEWSWIRE) — Lumos Pharma, Inc. (NASDAQ:LUMO), a biopharmaceutical company…